We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.23% | 480.00 | 460.00 | 480.00 | 470.00 | 465.00 | 465.00 | 33,518 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.95 | 222.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/11/2023 08:49 | Somebody isn't doing their job, I suspect some bean counter has found a cheaper solution. I was very active in TSTL years ago when I wrote this post and earlier. | melton john | |
22/11/2023 08:22 | Just spotted this report on MSN: "One of the primary chlorine disinfectants currently being used to clean hospital scrubs and surfaces does not kill off the most common cause of antibiotic-associate Research by the University of Plymouth has shown that spores of Clostridioides difficile, commonly known as C. diff, are completely unaffected despite being treated with high concentrations of bleach used in many hospitals. In fact, the chlorine chemicals are no more effective at damaging the spores when used as a surface disinfectant—t Writing in the journal Microbiology, the study's authors say susceptible people working and being treated in clinical settings might be unknowingly placed at risk of contracting the superbug. As a result, and with incidence of biocide overuse only serving to fuel rises in antimicrobial resistance (AMR) worldwide, they have called for urgent research to find alternative strategies to disinfect C. diff spores in order to break the chain of transmission in clinical environments." Perhaps they are not aware of Tristel’s Cache collection! | metis20 | |
16/11/2023 06:57 | Ready to try one of the JET Family hero? ... Family politics again !!! - it is what is done if a member misbehaves - and going back to comics, will Mr. CLEAN appear? | piedro | |
16/11/2023 06:46 | £65 for 2 pk of 800ml of the Jet ??? So Home Bargains won't be stocking this one then. | kaffee | |
16/11/2023 06:39 | A new website ... Home » JET Heroes Family When confronted with unknown risks, trust the JET Family to disinfect your surfaces. With its sporicidal efficacy in just one minute, these heroes are prepared to overcome unforeseen micro-biological challenges. | piedro | |
06/11/2023 19:23 | Me to. But it may not mover til Feb | petewy | |
06/11/2023 09:22 | just bought in here, high hopes for this one like Good Energy | oldboy1 | |
21/10/2023 09:52 | Bottom draw stuff. There are some smelly socks in there. Plus a few rude emails. | piedro | |
21/10/2023 09:08 | Great chart Piedro where did you get it? | cameronm | |
20/10/2023 23:43 | It has been a bumpy ride at times ... | piedro | |
19/10/2023 13:49 | Just noticed this line: Strongest ever outlook in Tristel's 30 year history driven by key North American regulatory approvals I figure Pedro must be off grid atm . I see IC have downgraded from Buy to Hold as they think it is already priced in.2024 prospective PE of 28 forecast. FWIW. Mind you they were correct in their last Buy call in FEB at 340p. | wad collector | |
17/10/2023 07:30 | Cash up to 12 million so from end of June 2.5 million in 3 months .Liz Dixon mentioned in her presentation it guess work but would imagine that’s end of September. Growth is obviously continuing to accelerate with Parker royalty contribution just getting started 25% growth looks readily achievable. The surprising comment was the belief that the new Cache product could equal or surpass Duo | best1467 | |
16/10/2023 09:33 | Financial Highlights -- Turnover of GBP36.0m (2022: GBP31.1m), a 16% increase. 22% growth to GBP36.0m from continuing products (2022: GBP29.6m) -- Overseas sales continue to grow, up 17% to GBP23.5m (2022: GBP20.1m), representing 65% of total sales (2022: 65%) -- Gross margin increased to 81% (2022: 80%) -- Adjusted EBITDA* margin of 25% (2022: 24%) -- Adjusted pre-tax profit* of GBP6.2m (2022: GBP4.5m) slightly above consensus forecasts -- Reported pre-tax profit of GBP5.1m (2022: GBP1.6m) -- Adjusted EPS* up 39% to 10.67p (2022: 7.68p). Basic EPS of 9.44p (2022: 2.09p) -- Dividend per share for the full year up 10% to 10.50p (2022: 9.55p) -- Cash of GBP9.5m (2022: GBP8.9m), with continued strong operating cashflow of GBP8.4m in the year (2022: GBP5.6m) * before share-based payments, and impairment of intangibles in FY 2022 | wad collector | |
16/10/2023 07:23 | JUST TRISTEL QUALITY AS USUAL | best1467 | |
14/10/2023 14:56 | Register for the seminar mentioned in the previous post (which includes a presentation from TSTL) here: | timbo003 | |
14/10/2023 11:41 | ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Tristel Plc (TSTL) and other healthcare companies like Inspiration Healthcare Group (IHC), Creo Medical Group (CREO), Abingdon Health (ABDX) and GENincode (GENI). 📍🌐 Attend in-person or online. Register: [...] | sharesoc | |
11/10/2023 14:35 | Roll on Monday.... | zimbtrader | |
04/10/2023 22:10 | Tristel Global@TristelGlobal It’s great to be with @GlosIPC today at Bowden Hall Hotel for the IPC in Action Conference! We’ll be here all day to discuss Tristel’s innovations in infection prevention #IPCinAction #InfectionPrevention - a messy stand and a new flag - perhaps they wish to split the company in two - better to be bought out by Parker Labs. AIMHO, BWDIK. | piedro | |
21/9/2023 19:12 | Is this where we sell and reinvest after a fall? Repeated resistance at 430ish. Traders must have done well here. | mayers | |
01/9/2023 14:51 | Mark Brewer writes the research notes (which are excellent). Geoff Nash is the lead on corporate finance. We will find out in due course if both have exited and where they end up. | james188 | |
01/9/2023 14:35 | I concur Glaws2, it is Mark Brewer. | immokalee | |
01/9/2023 14:22 | I thought it was Mark Brewer from Finncap | glaws2 | |
01/9/2023 07:14 | finncap have put out an RNS this morning on the merger with Cenkos. Amongst other things, it states that Geoff Nash has resigned. He has been the key contact for TSTL for many years. I wonder whether TSTL will now change brokers. | james188 | |
15/8/2023 15:45 | Does anyone have the note from Finncap - the broker research mentioned in the open day. Apologies if already posted. | mozy123 | |
12/8/2023 13:08 | Excellent link, Piedro. Thank you. apad | apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions